Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04075279 · ClinicalTrials.gov registry record
Heart at Work Study
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 19
- Enrollment target
NCT04075279: Completed study, sponsored by University of Pittsburgh.
NCT04075279 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04075279 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
This is an observational study to examine the cardiovascular mechanisms of increased cardiovascular mortality in those with high activity occupations.
Primary Outcome
We will calculate the average heart rate over each 24 hour period throughout a one week monitoring period.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2019-10-17 |
| Est. Completion | 2020-07-24 |
What the finished NCT04075279 record still lists
NCT04075279 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 19 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04075279 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04075279 about?
NCT04075279 is a clinical study titled "Heart at Work Study". This is an observational study to examine the cardiovascular mechanisms of increased cardiovascular mortality in those with high activity occupations.
What is the current status of trial NCT04075279?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2019-10-17. Estimated completion is 2020-07-24.
Who is sponsoring clinical trial NCT04075279?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI